Register Login

FATE THERAPEUTICS INC (FATE)

TAHL CINDY 🟡 adjusted position in 0 shares (2 derivative) of FATE THERAPEUTICS INC (FATE) at $1.32 Transaction Date: May 06, 2026 | Filing ID: 211820

Full text
Register to leave comments
  • News bot May 7, 2026, 8:01 p.m.

    🔍 TAHL CINDY (Executive)

    Company: FATE THERAPEUTICS INC (FATE)

    Report Date: 2026-05-06

    Transaction Summary:

    • Total transactions: 4
    • Derivative instruments: 2
    • Holdings reported: 0
    • Total shares acquired: 166,664
    • Total shares sold: 166,664

    Detailed Transactions and Holdings:

    • Acquired 122,220 shares of Common Stock at $1.32 per share (Direct)
      Date: 2026-05-06 | Code: M | equity_swap_involved: false | shares_owned_after: 609,301.00 | transaction_form_type: 4
    • Acquired 44,444 shares of Common Stock at $1.05 per share (Direct)
      Date: 2026-05-06 | Code: M | equity_swap_involved: false | shares_owned_after: 653,745.00 | transaction_form_type: 4
    • Sold 122,220 shares of Stock Option (Right to Buy) at $1.32 per share (Derivative)
      Date: 2026-05-06 | Code: M | Expires: 2035-01-14 | equity_swap_involved: false | shares_owned_after: 152,780.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 44,444 shares of Stock Option (Right to Buy) at $1.05 per share (Derivative)
      Date: 2026-05-06 | Code: M | Expires: 2036-01-14 | equity_swap_involved: false | shares_owned_after: 355,556.00 | transaction_form_type: 4 | Footnotes: F2

    Footnotes:

    • F1: The shares subject to this option shall vest in 36 equal monthly installments following January 1, 2025, such that all of the shares shall be fully vested and exercisable on January 1, 2028, subject to the Reporting Person's continued service with the Issuer as of each such vesting date.
    • F2: The shares subject to this option shall vest in 36 equal monthly installments following January 1, 2026, such that all of the shares shall be fully vested and exercisable on January 1, 2029, subject to the Reporting Person's continued service with the Issuer as of each such vesting date.
    • REMARKS: Chief Legal and Compliance Officer

Search

News categories